UBLITUXIMAB vs UMBRALISIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
UBLITUXIMAB vs UMBRALISIB: Safety Overview
| Metric | UBLITUXIMAB | UMBRALISIB |
|---|---|---|
| Total FAERS Reports | 1,582 | 293 |
| Deaths Reported | 27 | 30 |
| Death Rate | 1.7% | 10.2% |
| Hospitalizations | 213 | 97 |
| Average Patient Age | 49.7 yrs | 69.0 yrs |
| % Female Patients | 73.4% | 43.8% |
| FDA Approval Date | N/A | Feb 5, 2021 |
| Manufacturer | TG Therapeutics, Inc. | N/A |
| Route | INTRAVENOUS | N/A |
| Marketing Status | N/A | Discontinued |